Jae Eun Chung

Jae Eun Chung


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
YKYoung Ah Kim
Young Ah Kim
KLKyungwon Lee
Kyungwon Lee
JCJae Eun Chung
Jae Eun Chung
Escherichia coli (E. coli) is known to cause urinary tract infection (UTI) and meningitis in neonates, as well as existing as a commensal flora of the human gut. Extended-spectrum β-lactamase (ESBL)-producing E. coli has increased in the community with the spread of CTX-M type ESBL-producing sequence type 131 (ST131)-O25-H30Rx E. coli clone. The role of ESBL-producing E. coli in female genital tract infection has not been elucidated. The clinical and molecular features of E. coli isolated from community-onset female genital tract infections were evaluated to elucidate the current burden in the community, focusing on the highly virulent and multidrug-resistant ST131 clone. We collected and sequenced 91 non-duplicated E. coli isolates from the female genital tract of 514 patients with community-onset vaginitis. ESBL genotypes were identified by PCR and confirmed to be ESBL-producers by sequencing methods. ST131 clones were screened by PCR for O16-ST131 and O25b-ST131. Pulsed-field gel electrophoresis (PFGE) and PCR-based replicon typing (PBRT) were conducted in ESBL producers. Independent clinical risk factors associated with acquiring ESBL-producing E. coli and ST131 clone were analyzed using multivariate logistic regression analysis. Of the 514 consecutive specimens obtained from the infected female genital tract, 17.7% (91/514) had E. coli infection, of which 19.8% (18/91) were ESBL producers. CTX-M-15 was the most common type (n = 15). O25b-ST131 and O16-ST131 clones accounted for 15.4% (14/91) and 6.6% (6/91), respectively. In plasmid analysis, ten isolates succeeded in conjugation and plasmid types were IncFII (n = 4), IncFI (n = 3), IncI1-Iγ (n = 3) with one non-typable case. Compared to ESBL-nonproducing E. coli, ESBL-producing E. coli acquisition was strongly associated with recurrent vaginitis (OR 40.130; 95% CI 9.980-161.366), UTI (OR 18.915; 95% CI 5.469-65.411), and antibiotics treatment (OR 68.390; 95% CI 14.870-314.531). A dominant clone of CTX-M type ESBL-producing E. coli in conjugative plasmids seems to be circulating in the community and considerable number of ST131 E. coli in the genital tract of Korean women was noted. Sustained monitoring of molecular epidemiology and control of the high-risk group is needed to prevent ESBL-producing E. coli from spreading throughout the community.

1 March 2021 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
ILIn Ok Lee
In Ok Lee
JKJung Chul Kim
Jung Chul Kim
JSJong Wook Seo
Jong Wook Seo
HPHae Yong Pak
Hae Yong Pak
JCJae Eun Chung
Jae Eun Chung
This study aimed to investigate the risk of developing major depressive disorder (MDD) in women with polycystic ovary syndrome (PCOS). As a population-based retrospective cohort study based on the Korean National Health Insurance Claims Database and National Health Information Database, newly diagnosed 26,251 women with PCOS with age matched 131,480 women without PCOS from 2007 to 2010 were followed longitudinally and the subsequent occurrence of newly onset MDD was evaluated. The risk of developing MDD in women with PCOS after adjusting for various confounding variables was higher compared to women without PCOS (hazard ratio [HR]1.34, 95% confidence intervals [CI] 1.29–1.40, p<.0001). Stratified by the body mass index, the risk of being admitted to the hospital due to MDD was the highest in the overweight PCOS (HR 2.53, 95% CI 1.71–3.76, p<.0001). The risk of developing MDD was higher in women with PCOS compared to women without PCOS. Maintenance of the appropriate body weight should be emphasised as the hazard ratio of developing MDD was higher in overweight women with PCOS.

25 March 2022 in Gynecologic Robotic Surgery
Verified
Journal Article
Open access
PDF file
JSJong Wook Seo
Jong Wook Seo
ILIn Ok Lee
In Ok Lee
HYHye Soo Yoon
Hye Soo Yoon
KLKyung Lim Lee
Kyung Lim Lee
JCJae Eun Chung
Jae Eun Chung
Objective: To compare the perioperative outcomes of robotic single-site myomectomy (RSSM) and laparoendoscopic single-site myomectomy (LSSM).Methods: From January 2017 to December 2019, electronic medical records of the consecutively held 17 RSSM and 20 LSSM were reviewed. Parameters including patient’s characteristics, the total operation time, size and number of myomas taken out, operative findings, intra and postoperative complications were compared.Results: Patients who undertook RSSM were younger (27.0±7.1 vs. 32.9±7.9) and only one out of 17 (2.9%) had previous pregnancy compared to 10 out of 20 in LSSM (50.0%). Complex cases with tumors of larger size and accompanied adhesion were done using RSSM. The median operative time was longer in the RSSM (176.1±59.0 vs. 77.5±47.1). All cases were successfully performed via a single port. No cases of postoperative complication including wound dehiscence or intestinal obstruction occurred in either group.Conclusion: Perioperative outcomes of myomectomy undertaken by robotic single-site surgery and laparoendoscopic single-site surgery were comparable, though myomectomy for the larger myoma were performed with robotic single-site surgery. The role of robotic single-site myomectomy on fertility needs further investigation.

15 May 2020 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
JSJong Wook Seo
Jong Wook Seo
ILIn Ok Lee
In Ok Lee
JKJung Cheol Kim
Jung Cheol Kim
JCJae Eun Chung
Jae Eun Chung
Seo JW, et al. Obstet Gynecol Sci. 2020 May;63(3):387-394. https://doi.org/10.5468/ogs.2020.63.3.387

26 September 2018 in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
YKYeejeong Kim
Yeejeong Kim
ILIn Ok Lee
In Ok Lee
JCJae Eun Chung
Jae Eun Chung
Sertoli-Leydig cell tumors (SLCTs) arise from the non-germ cell component of the ovary and typically present in young women with evidence of hyperandrogenism such as precocious puberty, amenorrhea, hirsutism and virilization. It is very rare accounting for less than 0.2% of all ovarian tumors, and because of the rarity, no standardized treatment approach has reached a consensus. The prognosis is generally good with complete reversion of symptoms after surgery, although some cases have been reported to be malignant. Recently the need for DICER1 mutations testing in paediatric patients has been emphasized for the surveillance of possible synchronous tumors and affected family members. Authors present here a case of Sertoli-Leydig cell tumor incidentally found while performing a hysterectomy with bilateral salpingo-oophorectomy in a postmenopausal woman with endometrial hyperplasia that caused intractable vaginal bleeding.

1 October 2017 in Case Reports in Women's Health
Verified
Journal Article
Open access
YKYee Jeong Kim
Yee Jeong Kim
JKJoeng Hae Kie
Joeng Hae Kie
JCJae Eun Chung
Jae Eun Chung
•Coelomic metaplasia is considered to be one of the mechanisms resulting in endometriosis.•Intense ceolomic metaplasia resulted in a uterine like mass (ULM) acquiring the structural integrity of a miniature uterus.•ULM might be considered a rare manifestation in the spectrum of endometriosis development.